CO6930362A2 - Compuesto heterocíclico y su uso - Google Patents
Compuesto heterocíclico y su usoInfo
- Publication number
- CO6930362A2 CO6930362A2 CO14071857A CO14071857A CO6930362A2 CO 6930362 A2 CO6930362 A2 CO 6930362A2 CO 14071857 A CO14071857 A CO 14071857A CO 14071857 A CO14071857 A CO 14071857A CO 6930362 A2 CO6930362 A2 CO 6930362A2
- Authority
- CO
- Colombia
- Prior art keywords
- heterocyclic compound
- heterocyclic
- compound
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161532393P | 2011-09-08 | 2011-09-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6930362A2 true CO6930362A2 (es) | 2014-04-28 |
Family
ID=46940565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO14071857A CO6930362A2 (es) | 2011-09-08 | 2014-04-03 | Compuesto heterocíclico y su uso |
Country Status (31)
| Country | Link |
|---|---|
| US (9) | US9260420B2 (es) |
| EP (1) | EP2753617B9 (es) |
| JP (1) | JP6193848B2 (es) |
| KR (1) | KR101998441B1 (es) |
| CN (1) | CN103781783B (es) |
| AR (1) | AR087809A1 (es) |
| AU (1) | AU2012305212B2 (es) |
| BR (1) | BR112014005235B1 (es) |
| CA (1) | CA2847339C (es) |
| CO (1) | CO6930362A2 (es) |
| CY (1) | CY1118753T1 (es) |
| DK (1) | DK2753617T3 (es) |
| EA (1) | EA028160B1 (es) |
| ES (1) | ES2572934T3 (es) |
| HK (1) | HK1195550A1 (es) |
| HR (1) | HRP20160824T2 (es) |
| HU (1) | HUE027746T2 (es) |
| IL (1) | IL231116B (es) |
| JO (1) | JO3227B1 (es) |
| MX (1) | MX359515B (es) |
| MY (1) | MY196864A (es) |
| PL (1) | PL2753617T3 (es) |
| PT (1) | PT2753617T (es) |
| RS (1) | RS54894B9 (es) |
| SG (2) | SG10201601731RA (es) |
| SI (1) | SI2753617T1 (es) |
| SM (1) | SMT201600205B (es) |
| TW (1) | TWI568728B (es) |
| UA (1) | UA112993C2 (es) |
| WO (1) | WO2013035892A1 (es) |
| ZA (1) | ZA201401433B (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI320783B (en) * | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| JO3227B1 (ar) * | 2011-09-08 | 2018-03-08 | Otsuka Pharma Co Ltd | مشتقات بنزو ثيوفين بها استبدال ببرازين كعوامل مضادة للذهان |
| TW201332572A (zh) * | 2011-12-28 | 2013-08-16 | Otsuka Pharma Co Ltd | 具有經取代的β－環糊精之藥物製劑 |
| TWI562991B (en) * | 2012-04-23 | 2016-12-21 | Otsuka Pharma Co Ltd | Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same |
| JOP20200109A1 (ar) | 2012-04-23 | 2017-06-16 | Otsuka Pharma Co Ltd | مستحضر قابل للحقن |
| JP2014196292A (ja) * | 2013-03-07 | 2014-10-16 | 大塚製薬株式会社 | 医薬 |
| CN104447723A (zh) * | 2014-11-28 | 2015-03-25 | 瑞阳制药有限公司 | 7-(4-(4-(苯并[b]噻吩基)-1-哌嗪基)丁氧基)-2(1H)-喹啉酮的制备方法 |
| CN104829603A (zh) * | 2015-05-19 | 2015-08-12 | 杭州新博思生物医药有限公司 | A晶型依匹唑派盐酸盐及其制备方法 |
| WO2017162536A1 (en) | 2016-03-21 | 2017-09-28 | H. Lundbeck A/S | Vortioxetine prodrugs |
| PL233778B1 (pl) | 2016-07-19 | 2019-11-29 | Adamed Spolka Z Ograniczona Odpowiedzialnoscia | Sposob wytwarzania brekspiprazolu oraz zastosowanie zwiazkow posrednich w sposobie wytwarzania brekspiprazolu |
| WO2018048407A1 (en) * | 2016-09-08 | 2018-03-15 | Ford Motor Company | Methods and apparatus to monitor an activity level of a driver |
| CN106699745A (zh) * | 2016-12-14 | 2017-05-24 | 上海博志研新药物技术有限公司 | 一种依匹哌唑甲醇合物、晶型a、及其制备方法和应用 |
| US20180265472A1 (en) * | 2017-03-17 | 2018-09-20 | Scinopharm Taiwan, Ltd. | Process for preparing aripiprazole lauroxil and intermediates thereof |
| CN107628999B (zh) * | 2017-10-25 | 2019-07-02 | 苏州华健瑞达医药技术有限公司 | 阿立哌唑十二烷酸酯的制备方法 |
| CN109988162A (zh) * | 2017-12-29 | 2019-07-09 | 武汉兴华智慧医药科技有限公司 | 一种依匹哌唑衍生物及其制备方法 |
| CN110218209B (zh) * | 2018-03-02 | 2022-09-30 | 上海现代药物制剂工程研究中心有限公司 | 一种依匹哌唑月桂酸酯的晶型a、其制备方法及应用 |
| CN108947990A (zh) * | 2018-07-20 | 2018-12-07 | 成都苑东生物制药股份有限公司 | 一种苯并噻吩类化合物的制备方法 |
| JP7451538B2 (ja) * | 2019-01-11 | 2024-03-18 | ▲ユ▼展新藥生技股分有限公司 | ケタミンパモエート及びその使用 |
| TW202216676A (zh) * | 2020-07-06 | 2022-05-01 | 美商塔朵根公司 | 用於心理疾病或心理強化的有益苯并噻吩組合物 |
| US11229644B1 (en) * | 2020-12-31 | 2022-01-25 | Lake O'hara Llc | Methods of treating psychiatric disorders in obese patients with brexpiprazole |
| CN114044772A (zh) * | 2021-11-29 | 2022-02-15 | 浙江国邦药业有限公司 | 一种依匹哌唑合成方法及其中间体 |
| WO2024181403A1 (en) * | 2023-02-27 | 2024-09-06 | Otsuka Pharmaceutical Co., Ltd. | Piperazine-substituted benzothiophenes for treatment of mental disorders |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003263413A1 (en) * | 2002-09-17 | 2004-04-08 | Warner-Lambert Company Llc | Heterocyclic substituted piperazines for the treatment of schizophrenia |
| CN1989968B (zh) | 2002-12-27 | 2011-05-11 | 大塚制药株式会社 | 用于治疗情绪障碍的喹诺酮衍生物和5-羟色胺再摄取抑制剂 |
| US7160888B2 (en) | 2003-08-22 | 2007-01-09 | Warner Lambert Company Llc | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| US20050254575A1 (en) | 2004-05-12 | 2005-11-17 | Nokia Corporation | Multiple interoperability points for scalable media coding and transmission |
| DE102004031052A1 (de) | 2004-06-25 | 2006-01-12 | Bühler AG | System und Verfahren zur Mahlgut-Charakterisierung in einem Walzenstuhl |
| WO2006011246A1 (ja) | 2004-07-29 | 2006-02-02 | Magie Pression Co., Ltd. | ポリ乳酸糸で構成された布帛のプリーツ形成法およびプリーツ布帛 |
| TWI320783B (en) * | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| JP4315393B2 (ja) * | 2005-04-14 | 2009-08-19 | 大塚製薬株式会社 | 複素環化合物 |
| WO2006111246A1 (de) | 2005-04-18 | 2006-10-26 | Loi Thermprocess Gmbh | Industrieofen |
| JP4540700B2 (ja) | 2006-10-13 | 2010-09-08 | 大塚製薬株式会社 | 医薬 |
| JP2011136906A (ja) | 2008-04-18 | 2011-07-14 | Otsuka Pharmaceut Co Ltd | 複素環化合物 |
| AU2010266040B2 (en) | 2009-06-25 | 2015-01-15 | Alkermes Pharma Ireland Limited | Prodrugs of NH-acidic compounds |
| PT2445502T (pt) | 2009-06-25 | 2017-09-22 | Alkermes Pharma Ireland Ltd | Compostos heterocíclicos para o tratamento de distúrbios neurológicos e psicológicos |
| AU2010339689B2 (en) | 2010-01-07 | 2015-02-19 | Alkermes Pharma Ireland Limited | Quaternary ammonium salt prodrugs |
| CA2802733C (en) | 2010-06-24 | 2017-11-21 | Alkermes Pharma Ireland Limited | Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
| WO2012088441A1 (en) | 2010-12-23 | 2012-06-28 | Alkermes, Inc. | Multi- api loading prodrugs |
| RU2627469C2 (ru) | 2011-03-18 | 2017-08-08 | Алкермес Фарма Айэленд Лимитед | Фармацевтические композиции, содержащие водонерастворимое антипсихотическое средство и сложные эфиры сорбита |
| JO3227B1 (ar) * | 2011-09-08 | 2018-03-08 | Otsuka Pharma Co Ltd | مشتقات بنزو ثيوفين بها استبدال ببرازين كعوامل مضادة للذهان |
-
2012
- 2012-09-06 JO JOP/2012/0253A patent/JO3227B1/ar active
- 2012-09-07 AR ARP120103307A patent/AR087809A1/es not_active Application Discontinuation
- 2012-09-07 DK DK12766485.2T patent/DK2753617T3/en active
- 2012-09-07 AU AU2012305212A patent/AU2012305212B2/en active Active
- 2012-09-07 UA UAA201403486A patent/UA112993C2/uk unknown
- 2012-09-07 US US14/343,579 patent/US9260420B2/en active Active
- 2012-09-07 MX MX2014002254A patent/MX359515B/es active IP Right Grant
- 2012-09-07 EA EA201490585A patent/EA028160B1/ru not_active IP Right Cessation
- 2012-09-07 EP EP12766485.2A patent/EP2753617B9/en active Active
- 2012-09-07 ES ES12766485.2T patent/ES2572934T3/es active Active
- 2012-09-07 SI SI201230630A patent/SI2753617T1/sl unknown
- 2012-09-07 CN CN201280043980.2A patent/CN103781783B/zh active Active
- 2012-09-07 BR BR112014005235-2A patent/BR112014005235B1/pt active IP Right Grant
- 2012-09-07 MY MYPI2014700554A patent/MY196864A/en unknown
- 2012-09-07 KR KR1020147009258A patent/KR101998441B1/ko active IP Right Grant
- 2012-09-07 PT PT127664852T patent/PT2753617T/pt unknown
- 2012-09-07 SG SG10201601731RA patent/SG10201601731RA/en unknown
- 2012-09-07 TW TW101132738A patent/TWI568728B/zh active
- 2012-09-07 CA CA2847339A patent/CA2847339C/en active Active
- 2012-09-07 SG SG11201400148QA patent/SG11201400148QA/en unknown
- 2012-09-07 RS RS20160492A patent/RS54894B9/sr unknown
- 2012-09-07 PL PL12766485.2T patent/PL2753617T3/pl unknown
- 2012-09-07 HU HUE12766485A patent/HUE027746T2/en unknown
- 2012-09-07 JP JP2014511630A patent/JP6193848B2/ja active Active
- 2012-09-07 WO PCT/JP2012/073556 patent/WO2013035892A1/en active Application Filing
-
2014
- 2014-02-24 IL IL231116A patent/IL231116B/en active IP Right Grant
- 2014-02-25 ZA ZA2014/01433A patent/ZA201401433B/en unknown
- 2014-04-03 CO CO14071857A patent/CO6930362A2/es unknown
- 2014-08-29 HK HK14108815.0A patent/HK1195550A1/zh unknown
-
2015
- 2015-12-29 US US14/982,807 patent/US9539252B2/en active Active
-
2016
- 2016-06-30 SM SM201600205T patent/SMT201600205B/it unknown
- 2016-07-04 CY CY20161100617T patent/CY1118753T1/el unknown
- 2016-07-08 HR HRP20160824TT patent/HRP20160824T2/hr unknown
- 2016-11-23 US US15/359,809 patent/US20170071933A1/en not_active Abandoned
-
2017
- 2017-07-07 US US15/643,969 patent/US20180092907A1/en not_active Abandoned
-
2018
- 2018-07-12 US US16/033,749 patent/US20180318294A1/en not_active Abandoned
-
2019
- 2019-02-06 US US16/268,827 patent/US20190167672A1/en not_active Abandoned
- 2019-10-29 US US16/666,546 patent/US20200061056A1/en not_active Abandoned
-
2020
- 2020-06-09 US US16/896,329 patent/US20210052575A1/en not_active Abandoned
-
2022
- 2022-01-18 US US17/577,465 patent/US20230099694A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6930362A2 (es) | Compuesto heterocíclico y su uso | |
| CO6801774A2 (es) | Compuestos de benzotiazol y su uso farmacéutico | |
| SMT201600223B (it) | Composti eterociclici e loro uso come modulatori di tirosin chinasi di tipo iii | |
| CR20150380A (es) | Compuestos de carbamoilpiridona policíclicos y su uso farmacéutico | |
| SMT201500291B (it) | Nuovi agenti antimalarici | |
| CO6910189A2 (es) | Derivado heterociclico y farmacéutico | |
| BR112014000260A2 (pt) | composto, e, uso de um composto | |
| DK3141224T3 (da) | Stomipose med filterkonstruktion | |
| BR112013019509A2 (pt) | derivados heterocíclicos | |
| BR112012017441A2 (pt) | compostos e métodos | |
| CO6990717A2 (es) | Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina | |
| DK2540728T3 (da) | Heterocyklisk forbindelse | |
| DK2552261T3 (da) | Propfilter med proprum med aromakugle | |
| DK2594567T3 (da) | Heterocykliske alkynylbenzenforbindelser og anvendelser deraf | |
| DK3184136T3 (da) | Injektor | |
| CO6890099A2 (es) | Nuevos derivados dihidroquinolina-2-ona | |
| DK2590974T3 (da) | Tetrahydropyridopyrimidinderivater | |
| DK3415157T3 (da) | N-acyldipeptidderivater og anvendelser deraf | |
| BR112013010988A2 (pt) | composição fluída e uso | |
| BRPI1007494A2 (pt) | composto e uso do mesmo | |
| CO6920293A2 (es) | Compuestos antibaterianos y método para su uso | |
| CO6781486A2 (es) | Compuestos y su uso | |
| CO6890098A2 (es) | Compuesto pirazol y su uso farmaceutico | |
| BR112013029206A2 (pt) | composto, e, uso de um composto | |
| BR112013032360A2 (pt) | compostos inibidores de glioblastoma e seu uso |